If you are not happy with the results below please do another search
42 Technology (42T), FIND, the global alliance for diagnostics, and Rutgers University have worked together to develop an innovative stool sample processing kit that has played a central role in informing the World Health Organi-zation’s (WHO) recent policy update to improve the diagnosis of tuberculosis (TB) in children.
Insightful Science, a software company enabling the Cloud for Scientific Discovery, has acquired Protein Metrics, a leading provider of biopharmaceutical protein characterization and proteomics analysis software. The acquisition expands the company’s R&D value chain to widen the biopharmaceutical protein analysis arena, unblocking data analysis bottlenecks currently associated with large-scale protein studies.
GenNext Technologies, a growth-stage company providing instrumentation, software, and services, has earned a second patent protecting the company’s novel radical dosimetry technology which vastly improves the utility of protein footprinting for the study of biopharma-ceutical structure, function, and safety.
EKF Diagnostics, the global in vitro diagnostics company, has acquired Advanced Diagnostic Laboratory (“ADL Health”), a Texas based PCR-focused testing laboratory certified under the Clinical Laboratory Improvement Amendments (“CLIA”) for high-complexity molecular diagnostics testing. ADL Health’s CLIA-certified laboratory covers the fields of clinical, forensic and microbiological tests. The business has ISO 15189 Medical Laboratory accreditation […]
A collaboration between Cytel and Pulse Infoframe will support rare disease drug development sponsors seeking real-world evidence where the data generated can be used for a range of purposes, from synthetic controls and comparative effectiveness to pricing reimbursement. Cytel, a leader in the field of advanced analytics for life sciences, has spent the past 30 […]
AMSBIO has expanded its range of custom gene editing services to complement its extensive portfolio of off-the-shelf CRISPR/Cas9 products. AMSBIO CRISPR/Cas9 products are widely used by research groups worldwide in applications including gene mutation studies, epigenetic editing, cell and embryo therapies, and genomic-scale screening.
SOTIO Biotech, a clinical stage immuno-oncology company owned by PPF Group, announced an exclusive, target-specific license and option agreement with LegoChem Biosciences, a biotechnology company focused on developing its clinical-stage platform technology enabling antibody-drug conjugates (ADCs) with an excellent therapeutic index. SOTIO will obtain rights to deploy LCB’s ADC technology for up to five therapeutic […]
SciRhom GmbH, a therapeutic antibody developer, announced the addition of Dr. Jürgen Reeß to the management team as Chief Medical Officer. At the same time, the company is strengthening its business and scientific strategy with the establishment of a Board of Directors. The three members of the Board, Prof. Carl Blobel, Dr. Wolfgang Baiker, and […]
FUJIFILM Irvine Scientific, a leader in the development and manufacture of serum-free and chemically defined cell culture media for bioproduction and cell therapy manufacturing, announced the establishment of an Innovation and Collaboration Center in Suzhou New District, China. Through this new centre, experts will collaborate with customers to design upstream cell culture processes that […]
Researchers at Karolinska Institutet in Sweden report that a recently discovered inflammatory mediator, interleukin-26, appears to have an important role in pneumonia and contribute to the killing of bacteria. The study is published in the scientific journal Frontiers in Immunology – Microbial Immunology.
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
